Centene (NYSE:CNC) Shares Acquired Rep. Tim Moore

Representative Tim Moore (R-North Carolina) recently bought shares of Centene Corporation (NYSE:CNC). In a filing disclosed on August 05th, the Representative disclosed that they had bought between $1,001 and $15,000 in Centene stock on July 22nd.

Representative Tim Moore also recently made the following trade(s):

  • Purchased $15,001 – $50,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/30/2025.
  • Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/30/2025.
  • Purchased $15,001 – $50,000 in shares of Harley-Davidson (NYSE:HOG) on 7/30/2025.
  • Purchased $15,001 – $50,000 in shares of Verizon Communications (NYSE:VZ) on 7/29/2025.
  • Purchased $15,001 – $50,000 in shares of Intel (NASDAQ:INTC) on 7/29/2025.
  • Purchased $1,001 – $15,000 in shares of Krispy Kreme (NASDAQ:DNUT) on 7/29/2025.
  • Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/29/2025.
  • Purchased $1,001 – $15,000 in shares of UnitedHealth Group (NYSE:UNH) on 7/21/2025.
  • Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/21/2025.
  • Purchased $15,001 – $50,000 in shares of Centene (NYSE:CNC) on 7/18/2025.

Centene Stock Performance

Shares of NYSE:CNC opened at $25.20 on Thursday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.10. Centene Corporation has a 1 year low of $25.11 and a 1 year high of $80.59. The firm has a market capitalization of $12.37 billion, a PE ratio of 6.24, a P/E/G ratio of 1.06 and a beta of 0.40. The business’s 50 day moving average price is $42.15 and its 200-day moving average price is $54.03.

Centene (NYSE:CNCGet Free Report) last released its earnings results on Friday, July 25th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.39). The business had revenue of $48.74 billion for the quarter, compared to analysts’ expectations of $44.71 billion. Centene had a return on equity of 9.57% and a net margin of 1.15%. Centene’s quarterly revenue was up 22.4% compared to the same quarter last year. During the same period in the previous year, the company earned $2.42 EPS. As a group, equities research analysts expect that Centene Corporation will post 6.86 earnings per share for the current fiscal year.

Insider Activity at Centene

In related news, Director Theodore R. Samuels II purchased 9,000 shares of Centene stock in a transaction on Monday, July 28th. The shares were bought at an average price of $27.62 per share, with a total value of $248,580.00. Following the transaction, the director directly owned 32,000 shares of the company’s stock, valued at approximately $883,840. This trade represents a 39.13% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.36% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CNC. MassMutual Private Wealth & Trust FSB lifted its stake in Centene by 8.8% during the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 2,092 shares of the company’s stock worth $127,000 after acquiring an additional 169 shares in the last quarter. Quadcap Wealth Management LLC boosted its stake in shares of Centene by 3.2% in the first quarter. Quadcap Wealth Management LLC now owns 5,617 shares of the company’s stock valued at $341,000 after purchasing an additional 172 shares during the period. Poinciana Advisors Group LLC grew its holdings in shares of Centene by 2.8% in the first quarter. Poinciana Advisors Group LLC now owns 7,221 shares of the company’s stock valued at $438,000 after purchasing an additional 195 shares in the last quarter. Carnegie Investment Counsel lifted its holdings in Centene by 6.0% during the 1st quarter. Carnegie Investment Counsel now owns 3,811 shares of the company’s stock worth $234,000 after buying an additional 215 shares in the last quarter. Finally, Allworth Financial LP boosted its position in Centene by 6.1% in the 1st quarter. Allworth Financial LP now owns 4,387 shares of the company’s stock valued at $270,000 after buying an additional 254 shares during the period. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

CNC has been the subject of a number of recent research reports. Mizuho cut their price objective on shares of Centene from $71.00 to $40.00 and set a “neutral” rating for the company in a report on Friday, July 11th. Wells Fargo & Company downgraded Centene from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $72.00 to $30.00 in a research report on Wednesday, July 23rd. TD Cowen restated a “hold” rating and issued a $33.00 target price (down from $73.00) on shares of Centene in a report on Monday, July 21st. Wall Street Zen lowered Centene from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. Finally, Guggenheim reissued a “neutral” rating on shares of Centene in a report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $42.20.

Get Our Latest Analysis on Centene

About Representative Moore

Timothy K. Moore (Republican Party) is a member of the U.S. House, representing North Carolina’s 14th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Moore (Republican Party) ran for election to the U.S. House to represent North Carolina’s 14th Congressional District. He won in the general election on November 5, 2024.

Moore served as speaker of the House from 2015 to 2025.

Timothy Moore earned his B.A. from the University of North Carolina-Chapel Hill in 1992 and his J.D. from the Oklahoma City University School of Law in 1995. His professional experience includes working as an attorney.

About Centene

(Get Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Recommended Stories

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.